Latest Strategic Partnership News

Star Minerals has completed a $1.6 million placement, welcoming Bain Global Resources as a strategic investor and gearing up for drilling at its Tumblegum South Gold Project.

BetMakers Technology Group reports solid Q3 FY25 financial gains alongside a strategic binding agreement to acquire Nevada’s LVDC, expanding its global racing technology footprint.

Adveritas Limited reports a record 61% increase in annualised recurring revenue, driven by strong gains in sports betting and new product launches, while preparing for a strategic expansion into North America.

Black Cat Syndicate reports robust operational progress at its Kal East Gold Operation, surpassing expectations at the Lakewood processing facility and achieving early cash flow positivity at the Myhree open pit. Development activities at Majestic and Fingals advance as the company expands production capacity.

Everest Metals Corporation has completed a breakthrough engineering study demonstrating 97% rubidium recovery at its Mt Edon project, advancing Australia’s entry into the global rubidium market with a patented extraction process.

Blue Star Helium has successfully drilled the State 9 well at its Galactica helium project in Colorado, confirming natural gas flow and progressing towards production. Laboratory tests on helium and CO2 concentrations are underway as the company prepares for production tie-in.

Strickland Metals has reported a significant high-grade gold intercept at its Gradina Prospect within the Rogozna Project, Serbia, advancing its maiden resource plans.

Ioneer Ltd has announced a 308% increase in the Ore Reserve for its Rhyolite Ridge Lithium-Boron Project in Nevada, extending mine life to 95 years and confirming robust economics with low-cost lithium production and a stable boric acid revenue stream.

ReNerve Limited has entered a strategic partnership with Berkeley Biologics to develop and commercialise two new tissue-based product ranges, aiming to expand its footprint in the US surgical market by the end of 2025.

Papyrus Australia has secured a pivotal contract with UniSA to establish a Rapid Prototyping and R&D facility, advancing its sustainable packaging technology and commercial production plans.

Amplia Therapeutics reports strong progress in its pancreatic cancer drug development, completing the ACCENT trial recruitment ahead of schedule and initiating a new US trial, while managing a $6.57 million loss for FY25.

Tamboran Resources has successfully closed the first tranche of its PIPE, raising US$38.7 million to advance its Beetaloo Basin projects, with a second tranche pending shareholder approval.